Ion-sensitive in situ hydrogels of natamycin bilosomes for enhanced and prolonged ocular pharmacotherapy: in vitro permeability, cytotoxicity and in vivo evaluation

References

• Rowe-Rendleman CL, Durazo SA, Kompella UB, et al. Drug and gene delivery to the back of the eye: from bench to bedside. Invest Ophthalmol Vis Sci. 2014;55:2714–2730.
   PubMed Web of Science ®Google Scholar
• Urtti A. Challenges and obstacles of ocular pharmacokinetics and drug delivery. Adv Drug Deliv Rev. 2006;58:1131–1135.
   PubMed Web of Science ®Google Scholar
• Patel A, Cholkar K, Agrahari V, et al. Ocular drug delivery systems: an overview. World J Pharmacol. 2013;2:47–64.
   PubMedGoogle Scholar
• Ali M, Byrne ME. Challenges and solutions in topical ocular drug-delivery systems. Expert Rev Clin Pharmacol. 2008;1:145–161.
   PubMed Web of Science ®Google Scholar
• Huang D, Chen YS, Rupenthal ID. Overcoming ocular drug delivery barriers through the use of physical forces. Adv Drug Deliv Rev. 2017. DOI:https://doi.org/10.1016/j.addr.2017.09.008.
   Google Scholar
• Adelli GR, Balguri SP, Bhagav P, et al. Diclofenac sodium ion exchange resin complex loaded melt cast films for sustained release ocular delivery. Drug Deliv. 2017;24:370–379.
   PubMed Web of Science ®Google Scholar
• Balguri SP, Adelli GR, Tatke A, et al. Melt-cast noninvasive ocular inserts for posterior segment drug delivery. J Pharm Sci. 2017;106:3515–3523.
   PubMed Web of Science ®Google Scholar
• Jain D, Kumar V, Singh S, et al. Newer trends in in situ gelling systems for controlled ocular drug delivery. Japlr. 2016;2:1–16.
   Google Scholar
• Bhardwaj A, Kumar L, Mehta S, et al. Stimuli-sensitive systems–an emerging delivery system for drugs. Artif Cells Nanomed Biotechnol. 2015;43:299–310.
   PubMed Web of Science ®Google Scholar
• Imam SS, Bukhari SNA, Ali A. Preparation and evaluation of novel chitosan: gelrite ocular system containing besifloxacin for topical treatment of bacterial conjunctivitis: scintigraphy, ocular irritation and retention assessment. Artif Cells Nanomed Biotechnol. 2017. DOI:https://doi.org/10.1080/21691401.2017.1349779
   Google Scholar
• Sheshala R, Kok YY, Ng JM, et al. In situ gelling ophthalmic drug delivery system: an overview and its applications. Recent Pat Drug Deliv Formul. 2015;9:237–248.
   PubMedGoogle Scholar
• Rupenthal ID, Green CR, Alany RG. Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 1: physicochemical characterisation and in vitro release. Int J Pharm. 2011;411:69–77.
   PubMed Web of Science ®Google Scholar
• Kushwaha SK, Saxena P, Rai A. Stimuli sensitive hydrogels for ophthalmic drug delivery: a review. Int J Pharma Investig. 2012;2:54–60.
   PubMedGoogle Scholar
• Mun EA, Morrison PW, Williams AC, et al. On the barrier properties of the cornea: a microscopy study of the penetration of fluorescently labeled nanoparticles, polymers, and sodium fluorescein. Mol Pharmaceutics. 2014;11:3556–3564.
   PubMed Web of Science ®Google Scholar
• Balguri SP, Adelli GR, Janga KY, et al. Ocular disposition of ciprofloxacin from topical, PEGylated nanostructured lipid carriers: effect of molecular weight and density of poly (ethylene) glycol. Int J Pharm. 2017;529:32–43.
   PubMed Web of Science ®Google Scholar
• Balguri SP, Adelli GR, Majumdar S. Topical ophthalmic lipid nanoparticle formulations (SLN, NLC) of indomethacin for delivery to the posterior segment ocular tissues. Eur J Pharm Biopharm. 2016;109:224–235.
   PubMed Web of Science ®Google Scholar
• Mandal A, Bisht R, Rupenthal ID, et al. Polymeric micelles for ocular drug delivery: from structural frameworks to recent preclinical studies. J Control Release. 2017;248:96–116.
   PubMed Web of Science ®Google Scholar
• Ikuta Y, Aoyagi S, Tanaka Y, et al. Creation of nano eye-drops and effective drug delivery to the interior of the eye. Sci Rep. 2017; 7:44229.
   PubMed Web of Science ®Google Scholar
• Bardania H, Tarvirdipour S, Dorkoosh F. Liposome-targeted delivery for highly potent drugs. Artif Cells Nanomed Biotechnol. 2017;45:1478–1489.
   PubMed Web of Science ®Google Scholar
• Abdelkader H, Ismail S, Hussein A, et al. Conjunctival and corneal tolerability assessment of ocular naltrexone niosomes and their ingredients on the hen's egg chorioallantoic membrane and excised bovine cornea models. Int J Pharm. 2012;432:1–10.
   PubMed Web of Science ®Google Scholar
• Kumar D, Jain N, Gulati N, et al. Nanoparticles laden in situ gelling system for ocular drug targeting. J Adv Pharm Tech Res. 2013;4:9–17.
   PubMedGoogle Scholar
• Pandurangan DK, Bodagala P, Palanirajan VK, et al. Formulation and evaluation of voriconazole ophthalmic solid lipid nanoparticles in situ gel. Int J Pharma Investig. 2016;6:56–62.
   PubMed Web of Science ®Google Scholar
• Morsi N, Ibrahim M, Refai H, et al. Nanoemulsion-based electrolyte triggered in situ gel for ocular delivery of acetazolamide. Eur J Pharm Sci. 2017;104:302–314.
   PubMed Web of Science ®Google Scholar
• Ibrahim MM, Abd-Elgawad AH, Soliman OA, et al. Stability and ocular pharmacokinetics of celecoxib-loaded nanoparticles topical ophthalmic formulations. J Pharm Sci. 2016;105:3691–3701.
   PubMed Web of Science ®Google Scholar
• Paradkar MU, Parmar M. Formulation development and evaluation of natamycin niosomal in-situ gel for ophthalmic drug delivery. J Drug Deliv Sci Technol. 2017;39:113–122.
   Web of Science ®Google Scholar
• Shukla A, Mishra V, Kesharwani P. Bilosomes in the context of oral immunization: development, challenges and opportunities. Drug Discov Today. 2016;21:888–899.
   PubMed Web of Science ®Google Scholar
• Al-mahallawi AM, Abdelbary AA, Aburahma MH, et al. Investigating the potential of employing bilosomes as a novel vesicular carrier for transdermal delivery oftenoxicam. Int J Pharm. 2015;485:329–340.
   PubMed Web of Science ®Google Scholar
• Abdelbary AA, Abd-Elsalam WH, Al-Mahallawi AM. Fabrication of novel ultradeformable bilosomes for enhanced ocular delivery of terconazole: in vitro characterization, ex vivo permeation and in vivo safety assessment. Int J Pharm. 2016;513:688–696.
   PubMed Web of Science ®Google Scholar
• Tanure MAG, Cohen EJ, Sudesh S, et al. Spectrum of fungal keratitis at Wills eye hospital, Philadelphia, Pennsylvania. Cornea. 2000;19:307–312.
   PubMed Web of Science ®Google Scholar
• Phan CM, Subbaraman LN, Jones L. In vitro drug release of natamycin from β-cyclodextrin and 2-hydroxypropyl-β-cyclodextrin-functionalized contact lens materials. J Biomater Sci Polym Ed. 2014;25:1907–1919.
   PubMed Web of Science ®Google Scholar
• Bhatta RS, Chandasana H, Chhonker YS, et al. Mucoadhesive nanoparticles for prolonged ocular delivery of natamycin: in vitro and pharmacokinetics studies. Int J Pharm. 2012;432:105–112.
   PubMed Web of Science ®Google Scholar
• Thangabalan B, Kumar PV. Analytical method development and validation of natamycin in eye drop by RP-HPLC. Asian J Pharm Clin Res. 2013;6:134–135.
   Google Scholar
• Abdelkader H, Ismail S, Kamal A, et al. Design and evaluation of controlled-release niosomes and discomes for naltrexone hydrochloride ocular delivery. J Pharm Sci. 2011;100:1833–1846.
   PubMed Web of Science ®Google Scholar
• Nagesh C, Patil M, Chandrashekar S, et al. A novel in situ gel for sustained ophthalmic delivery of ciprofloxacin hydrochloride and dexamethasone- design and characterization. Der Pharmacia Lett. 2012;4:821–827.
   Google Scholar
• Tai A, Bianchini R, Jachowicz J. Texture analysis of cosmetic/pharmaceutical raw materials and formulations. Int J Cosmet Sci. 2014;36:291–304.
   PubMed Web of Science ®Google Scholar
• Ibrahim MM, Abd-Elgawad AE, Soliman OA, et al. Nanoparticle-based topical ophthalmic formulations for sustained celecoxib release. J Pharm Sci. 2013;102:1036–1053.
   PubMed Web of Science ®Google Scholar
• Majumdar S, Srirangam R. Solubility, stability, physicochemical characteristics and in vitro ocular tissue permeability of hesperidin: a natural bioflavonoid. Pharm Res. 2009;26:1217–1225.
   PubMed Web of Science ®Google Scholar
• Kakkar S, Kaur IP. Spanlastics-a novel nanovesicular carrier system for ocular delivery. Int J Pharm. 2011;413:202–210.
   PubMed Web of Science ®Google Scholar
• Zhang J, Xue R, Ong WY, et al. Roles of cholesterol in vesicle fusion and motion. Biophys J. 2009;97:1371–1380.
   PubMed Web of Science ®Google Scholar
• Janga KY, Jukanti R, Velpula A, et al. Bioavailability enhancement of zaleplon via proliposomes: role of surface charge. Eur J Pharm Biopharm. 2012;80:347–357.
   PubMed Web of Science ®Google Scholar
• Dai Y, Zhou R, Liu L, et al. Liposomes containing bile salts as novel ocular delivery systems for tacrolimus (FK506): in vitro characterization and improved corneal permeation. Int J Nanomed. 2013;8:1921–1933.
   PubMed Web of Science ®Google Scholar
• El Zaafarany GM, Awad GA, Holayel SM, et al. Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery. Int J Pharm. 2010;397:164–172.
   PubMed Web of Science ®Google Scholar
• Salama HA, Mahmoud AA, Kamel AO, et al. Brain delivery of olanzapine by intranasal administration of transfersomal vesicles. J Liposome Res. 2012;22:336–345.
   PubMed Web of Science ®Google Scholar
• Niu M, Lu Y, Hovgaard L, et al. Liposomes containing glycocholate as potential oral insulin delivery systems: preparation, in vitro characterization, and improved protection against enzymatic degradation. Int J Nanomed. 2011;6:1155–1166.
   PubMed Web of Science ®Google Scholar
• Inactive ingredient search for approved drug products. Fedral Drug Administration IIG database-2017. Available from: https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm
   Google Scholar
• Uddin MS, Al Mamun A, Kabir MT, et al. Quality control tests for ophthalmic pharmaceuticals: pharmacopoeial standards and specifications. JAMPS. 2017;14:1–17.
   Google Scholar
• Khouryieh HA, Herald TJ, Aramouni F, et al. Intrinsic viscosity and viscoelastic properties of xanthan/guar mixtures in dilute solutions: effect of salt concentration on the polymer interactions. Food Res Int. 2007;40:883–893.
   Web of Science ®Google Scholar
• Dintzis F, Babcock G, Tobin R. Studies on dilute solutions and dispersion of the polysaccharide from xanthomonas campestris nrrl b-1459. Carbohydr Res. 1970;13:257–267.
   Web of Science ®Google Scholar
• Zignani M, Tabatabay C, Gurny R. Topical semi-solid drug delivery: kinetics and tolerance of ophthalmic hydrogels. Adv Drug Deliv Rev. 1995;16:51–60.
   Web of Science ®Google Scholar
• Shamma RN, Elsayed I. Transfersomal lyophilized gel of buspirone HCl: formulation, evaluation and statistical optimization. J Liposome Res. 2013;23:244–254.
   PubMed Web of Science ®Google Scholar
• Al-Halafi AM. Nanocarriers of nanotechnology in retinal diseases. Saudi J Ophthalmol. 2014;28:304–309.
   PubMedGoogle Scholar
• Barar J, Asadi M, Mortazavi-Tabatabaei SA, et al. Ocular drug delivery; impact of in vitro cell culture models. J Ophthalmic Vis Res. 2009;4:238–252.
   PubMedGoogle Scholar
• Yu W, do Egito EST, Barratt G, et al. A novel approach to the preparation of injectable emulsions by a spontaneous emulsification process. Int J Pharm. 1993;89:139–146.
   Web of Science ®Google Scholar